GlassScriptPhysician profile
Dylan Henry Menefee
NPI 1326650698
$13,720.05
in general payments reported to CMS, 2019-2025
22 companies · $930 in 2025
The $930 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $420 · 2022: $5,365 · 2023: $4,783 · 2024: $2,222 · 2025: $930.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,724 · Travel and Lodging: $3,077 · Education: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,724.33 |
| Travel and Lodging | $3,076.76 |
| Education | $134.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $9,376.64 | 2022-2025 | Micra, Linq II, Evera Mri Xt Dr Surescan |
| Boston Scientific Corporation | $702.55 | 2021-2025 | Watchman Access System, Mylux Patient Kit With Mobile Device, Watchman Flx |
| Alexion Pharmaceuticals, INC. | $510.89 | 2021-2024 | |
| Abbott Laboratories | $466.73 | 2021-2023 | Ensite Precision |
| E.R. Squibb & Sons, L.L.C. | $384.77 | 2022-2023 | Eliquis |
| Alnylam Pharmaceuticals INC. | $358.54 | 2022-2025 | Amvuttra, Onpattro |
| Cvrx, INC. | $264.56 | 2022-2023 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $249.80 | 2022-2023 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $160.70 | 2022-2025 | Lifevest |
| Novo Nordisk INC | $155.53 | 2023-2024 | Wegovy |
| Scpharmaceuticals INC. | $136.96 | 2023 | |
| Silk Road Medical, INC. | $129.24 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2025 | |
| Janssen Pharmaceuticals, INC | $106.00 | 2022 | |
| Esperion Therapeutics, INC. | $105.27 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $100.63 | 2022-2023 | |
| Edwards Lifesciences Corporation | $95.43 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| United Therapeutics Corporation | $94.23 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $89.00 | 2023 | Uptravi, Opsumit |
| Biosense Webster, INC. | $66.62 | 2025 | Carto 3 |
| Cardiva Medical, INC. | $26.89 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Glaxosmithkline, LLC. | $14.07 | 2025 | Arexvy, Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dylan Menefee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.